Suppr超能文献

用于评估个体生物等效性的容许区间使用的扩展。

Extension to the use of tolerance intervals for the assessment of individual bioequivalence.

作者信息

Esinhart J D, Chinchilli V M

机构信息

Center for Biostatistics, East Carolina University, School of Medicine, Greenville, North Carolina 27858-4354.

出版信息

J Biopharm Stat. 1994 Mar;4(1):39-52. doi: 10.1080/10543409408835071.

Abstract

For the determination of bioequivalence, researchers have recently shifted their emphasis from average bioequivalence alone to average and individual bioequivalence. Existing methods for assessing average bioequivalence were first developed for the standard 2 x 2 crossover design, but these methods are easily generalized to the two-treatment, p-period crossover designs (e.g., TRR, RTT, and TTRR, RRTT, TRRT, RTTR). With respect to individual bioequivalence, Westlake (1,2) implemented the use of parametric and distribution-free tolerance intervals for assessing individual bioequivalence. Anderson and Hauck (3) described what they call the test of individual equivalence ratios (TIER) for the same purpose. Note that these methods have been applied and/or developed only for the standard 2 x 2 crossover design. The present work extends the method of using parametric tolerance intervals for assessing individual bioequivalence.

摘要

为了确定生物等效性,研究人员最近已将重点从仅关注平均生物等效性转移到平均生物等效性和个体生物等效性。现有的评估平均生物等效性的方法最初是为标准的2×2交叉设计开发的,但这些方法很容易推广到两治疗组、p周期交叉设计(例如,TRR、RTT以及TTRR、RRTT、TRRT、RTTR)。关于个体生物等效性,韦斯特莱克(1,2)采用参数和非参数容忍区间来评估个体生物等效性。安德森和豪克(3)出于同样目的描述了他们所谓的个体等效比检验(TIER)。请注意,这些方法仅针对标准的2×2交叉设计进行了应用和/或开发。本研究扩展了使用参数容忍区间评估个体生物等效性的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验